BACKGROUND: The structural and functional changes of the skeletal muscles in idiopathic inflammatory myopathies (IIM) caused by inflammation and immune changes can be severely disabling. The objective of this study was to assess the effect of a 24-week program combining a supervised training of activities of daily living (ADL), resistance, and stability with home exercise for improving muscle function, compared to a daily home-based exercise representing the regular outpatient care. METHODS: Fifty-seven patients with IIM were consecutively and non-selectively enrolled in an intervention (IG, n = 30) or control (CG, n = 27) group. Both groups were provided a standard-of-care pharmacological treatment and follow-up. Only the IG underwent the supervised intervention twice a week for 1 h per session. At baseline, 12, 24, and 48 weeks, all patients were assessed by an assessor blinded to the intervention for primary outcomes: muscle strength (Manual Muscle Testing of eight muscle groups [MMT-8]) and endurance (Functional Index-2 [FI-2]), and secondary outcomes: stability and body composition. Secondary outcomes also included questionnaires evaluating disability (Health Assessment Questionnaire [HAQ]), quality of life (Short Form 36 [SF-36]), depression (Beck's Depression Inventory-II [BDI-II]), and fatigue (Fatigue Impact Scale [FIS]), and analysis of the systemic and local inflammatory response and perceived exertion to assess the safety of the intervention. RESULTS: Twenty-seven patients in the IG and 23 in the CG completed the entire program and follow-up. At week 24, compared to deterioration in the CG, we found a significant improvement in the IG in muscle strength (mean % improvement compared to baseline by 26%), endurance (135%), disability (39%), depression (26%), stability (11%), and basal metabolism (2%) and a stabilization of fitness for physical exercise. The improvement was clinically meaningful (a 24-week change by >20%) in most outcomes in a substantial proportion of patients. Although the improvement was still present at 48 weeks, the effect was not sustained during follow-up. No significant increase in the systemic or local expression of inflammatory markers was found throughout the intervention. CONCLUSIONS: This 24-week supervised intervention focused on ADL training proved to be safe and effective. It not only prevented the progressive deterioration, but also resulted in a significant improvement in muscle strength, endurance, stability, and disability, which was clinically meaningful in a substantial proportion of patients. TRIAL REGISTRATION: ISRCTN35925199 (retrospectively registered on 22 May 2020).

Department of Human Movement Laboratory Faculty of Physical Education and Sport Charles University Prague Czech Republic

Department of Methodology Faculty of Physical Education and Sport Charles University Prague Czech Republic

Department of Physiotherapy Faculty of Physical Education and Sport Charles University Prague Czech Republic

Department of Rheumatology 1st Faculty of Medicine Charles University Prague Czech Republic

Institute of Rheumatology Na Slupi 4 128 00 Prague 2 Czech Republic

Zobrazit více v PubMed

Lundberg IE, Miller FW, Tjarnlund A, Bottai M. Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med. 2016;280(1):39–51. doi: 10.1111/joim.12524. PubMed DOI PMC

Mandel DE, Malemud CJ, Askari AD. Idiopathic inflammatory myopathies: a review of the classification and impact of pathogenesis. Int J Mol Sci. 2017;18(5):1084. doi: 10.3390/ijms18051084. PubMed DOI PMC

Vencovsky J, Alexanderson H, Lundberg IE. Idiopathic inflammatory myopathies. Rheum Dis Clin N Am. 2019;45(4):569–581. doi: 10.1016/j.rdc.2019.07.006. PubMed DOI

Zong M, Lundberg IE. Pathogenesis, classification and treatment of inflammatory myopathies. Nat Rev Rheumatol. 2011;7(5):297–306. doi: 10.1038/nrrheum.2011.39. PubMed DOI

Lundberg IE, Vencovsky J, Alexanderson H. Therapy of myositis: biological and physical. Curr Opin Rheumatol. 2014;26(6):704–711. doi: 10.1097/BOR.0000000000000109. PubMed DOI

Dimachkie MM, Barohn RJ. Idiopathic inflammatory myopathies. Semin Neurol. 2012;32(3):227–236. doi: 10.1055/s-0032-1329201. PubMed DOI PMC

Regardt M, Welin Henriksson E, Sandqvist J, Lundberg IE, Schult ML. Work ability in patients with polymyositis and dermatomyositis: an explorative and descriptive study. Work. 2015;53(2):265–277. doi: 10.3233/WOR-152127. PubMed DOI

Furst DE, Amato AA, Iorga SR, Bancroft T, Fernandes AW. Medical costs and health-care resource use in patients with inflammatory myopathies in an insured population. Muscle Nerve. 2012;46(4):496–505. doi: 10.1002/mus.23384. PubMed DOI

Alexanderson H. Exercise in inflammatory myopathies, including inclusion body myositis. Curr Rheumatol Rep. 2012;14(3):244–251. doi: 10.1007/s11926-012-0248-4. PubMed DOI

Alexanderson H. Exercise in myositis. Curr Treatm Opt Rheumatol. 2018;4(4):289–298. doi: 10.1007/s40674-018-0113-3. PubMed DOI PMC

Habers GE, Takken T. Safety and efficacy of exercise training in patients with an idiopathic inflammatory myopathy--a systematic review. Rheumatology (Oxford) 2011;50(11):2113–2124. doi: 10.1093/rheumatology/ker292. PubMed DOI

Baschung Pfister P, de Bruin ED, Tobler-Ammann BC, Maurer B, Knols RH. The relevance of applying exercise training principles when designing therapeutic interventions for patients with inflammatory myopathies: a systematic review. Rheumatol Int. 2015;35(10):1641–1654. doi: 10.1007/s00296-015-3343-9. PubMed DOI

Van Thillo A, Vulsteke JB, Van Assche D, Verschueren P, De Langhe E. Physical therapy in adult inflammatory myopathy patients: a systematic review. Clin Rheumatol. 2019;38(8):2039–2051. doi: 10.1007/s10067-019-04571-9. PubMed DOI

Alexanderson H, Bostrom C. Exercise therapy in patients with idiopathic inflammatory myopathies and systemic lupus erythematosus - a systematic literature review. Best Pract Res Clin Rheumatol. 2020;34(2):101547. doi: 10.1016/j.berh.2020.101547. PubMed DOI

Zhang H, Liu Y, Ma J, Li Z. Systematic review of physical exercise for patients with idiopathic inflammatory myopathies. Nurs Health Sci. 2021. 10.1111/nhs.12817. Epub ahead of print. PubMed

Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts) N Engl J Med. 1975;292(7):344–347. doi: 10.1056/NEJM197502132920706. PubMed DOI

Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts) N Engl J Med. 1975;292(8):403–407. doi: 10.1056/NEJM197502202920807. PubMed DOI

Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004;14(5):337–345. doi: 10.1016/j.nmd.2004.02.006. PubMed DOI

Rose MR, Group EIW 188th ENMC International Workshop: Inclusion body myositis, 2-4 December 2011, Naarden, The Netherlands. Neuromuscul Disord. 2013;23(12):1044–1055. doi: 10.1016/j.nmd.2013.08.007. PubMed DOI

Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI) Arthritis Care Res. 2011;63(Suppl 11):S118–S157. doi: 10.1002/acr.20532. PubMed DOI PMC

Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483. doi: 10.1097/00005650-199206000-00002. PubMed DOI

Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18(Suppl 1):S79–S83. doi: 10.1093/clinids/18.Supplement_1.S79. PubMed DOI

Wang YP, Gorenstein C. Psychometric properties of the Beck Depression Inventory-II: a comprehensive review. Braz J Psychiatry. 2013;35(4):416–431. doi: 10.1590/1516-4446-2012-1048. PubMed DOI

Refardt J, Kling B, Krausert K, Fassnacht M, von Felten S, Christ-Crain M, Fenske W. Impact of chronic hyponatremia on neurocognitive and neuromuscular function. Eur J Clin Investig. 2018;48(11):e13022. doi: 10.1111/eci.13022. PubMed DOI

Abdel-Mageed SM, Mohamed EI. Total body capacitance for estimating human basal metabolic rate in an Egyptian population. Int J Biomed Sci. 2016;12(1):42–47. PubMed PMC

Staufer K, Halilbasic E, Hillebrand P, Harm S, Schwarz S, Jaksch P, Kivaranovic D, Klepetko W, Trauner M, Kazemi-Shirazi L. Impact of nutritional status on pulmonary function after lung transplantation for cystic fibrosis. United European Gastroenterol J. 2018;6(7):1049–1055. doi: 10.1177/2050640618778381. PubMed DOI PMC

Bunc V, Dlouha R, Moravcova J, Novak I, Hoskova Z, Cermakova M. Estimation of body composition by multifrequency bioimpedance measurement in children. Ann N Y Acad Sci. 2000;904:203–204. doi: 10.1111/j.1749-6632.2000.tb06450.x. PubMed DOI

Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–381. doi: 10.1249/00005768-198205000-00012. PubMed DOI

Noble BJ, Borg GA, Jacobs I, Ceci R, Kaiser P. A category-ratio perceived exertion scale: relationship to blood and muscle lactates and heart rate. Med Sci Sports Exerc. 1983;15(6):523–528. doi: 10.1249/00005768-198315060-00015. PubMed DOI

Miller FW, Lamb JA, Schmidt J, Nagaraju K. Risk factors and disease mechanisms in myositis. Nat Rev Rheumatol. 2018;14(5):255–268. doi: 10.1038/nrrheum.2018.48. PubMed DOI PMC

De Paepe B, Creus KK, De Bleecker JL. Role of cytokines and chemokines in idiopathic inflammatory myopathies. Curr Opin Rheumatol. 2009;21(6):610–616. doi: 10.1097/BOR.0b013e3283317b31. PubMed DOI

Moran EM, Mastaglia FL. Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications. Clin Exp Immunol. 2014;178(3):405–415. doi: 10.1111/cei.12445. PubMed DOI PMC

Cerezo LA, Vencovsky J, Senolt L. Cytokines and inflammatory mediators as promising markers of polymyositis/dermatomyositis. Curr Opin Rheumatol. 2020;32(6):534–541. doi: 10.1097/BOR.0000000000000744. PubMed DOI

Shireman PK, Contreras-Shannon V, Reyes-Reyna SM, Robinson SC, McManus LM. MCP-1 parallels inflammatory and regenerative responses in ischemic muscle. J Surg Res. 2006;134(1):145–157. doi: 10.1016/j.jss.2005.12.003. PubMed DOI

Aggarwal R, Rider LG, Ruperto N, Bayat N, Erman B, Feldman BM, Oddis CV, Amato AA, Chinoy H, Cooper RG, Dastmalchi M, Fiorentino D, Isenberg D, Katz JD, Mammen A, de Visser M, Ytterberg SR, Lundberg IE, Chung L, Danko K, García-de la Torre I, Song YW, Villa L, Rinaldi M, Rockette H, Lachenbruch PA, Miller FW, Vencovsky J, International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: an International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2017;76(5):792–801. doi: 10.1136/annrheumdis-2017-211400. PubMed DOI PMC

Miller FW. New approaches to the assessment and treatment of the idiopathic inflammatory myopathies. Ann Rheum Dis. 2012;71(Suppl 2):i82–i85. doi: 10.1136/annrheumdis-2011-200587. PubMed DOI

Tiffreau V, Rannou F, Kopciuch F, Hachulla E, Mouthon L, Thoumie P, Sibilia J, Drumez E, Thevenon A. Postrehabilitation functional improvements in patients with inflammatory myopathies: the results of a randomized controlled trial. Arch Phys Med Rehabil. 2017;98(2):227–234. doi: 10.1016/j.apmr.2016.09.125. PubMed DOI

Alexanderson H, Munters LA, Dastmalchi M, Loell I, Heimburger M, Opava CH, et al. Resistive home exercise in patients with recent-onset polymyositis and dermatomyositis -- a randomized controlled single-blinded study with a 2-year followup. J Rheumatol. 2014;41(6):1124–1132. doi: 10.3899/jrheum.131145. PubMed DOI

Alemo Munters L, Dastmalchi M, Katz A, Esbjornsson M, Loell I, Hanna B, et al. Improved exercise performance and increased aerobic capacity after endurance training of patients with stable polymyositis and dermatomyositis. Arthritis Res Ther. 2013;15(4):R83. doi: 10.1186/ar4263. PubMed DOI PMC

Alemo Munters L, Dastmalchi M, Andgren V, Emilson C, Bergegard J, Regardt M, et al. Improvement in health and possible reduction in disease activity using endurance exercise in patients with established polymyositis and dermatomyositis: a multicenter randomized controlled trial with a 1-year open extension followup. Arthritis Care Res. 2013;65(12):1959–1968. doi: 10.1002/acr.22068. PubMed DOI

Wiesinger GF, Quittan M, Aringer M, Seeber A, Volc-Platzer B, Smolen J, Graninger W. Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. Br J Rheumatol. 1998;37(2):196–200. doi: 10.1093/rheumatology/37.2.196. PubMed DOI

Mattar MA, Gualano B, Perandini LA, Shinjo SK, Lima FR, Sa-Pinto AL, et al. Safety and possible effects of low-intensity resistance training associated with partial blood flow restriction in polymyositis and dermatomyositis. Arthritis Res Ther. 2014;16(5):473. doi: 10.1186/s13075-014-0473-5. PubMed DOI PMC

Mattar MA, Gualano B, Roschel H, Perandini LA, Dassouki T, Lima FR, Shinjo SK, de Sá Pinto AL. Exercise as an adjuvant treatment in persistent active polymyositis. J Clin Rheumatol. 2014;20(1):11–15. doi: 10.1097/RHU.0000000000000056. PubMed DOI

Alexanderson H, Dastmalchi M, Esbjornsson-Liljedahl M, Opava CH, Lundberg IE. Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. Arthritis Rheum. 2007;57(5):768–777. doi: 10.1002/art.22780. PubMed DOI

Varju C, Petho E, Kutas R, Czirjak L. The effect of physical exercise following acute disease exacerbation in patients with dermato/polymyositis. Clin Rehabil. 2003;17(1):83–87. doi: 10.1191/0269215503cr572oa. PubMed DOI

Alexanderson H, Stenstrom CH, Jenner G, Lundberg I. The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis. Scand J Rheumatol. 2000;29(5):295–301. doi: 10.1080/030097400447679. PubMed DOI

Alexanderson H, Stenstrom CH, Lundberg I. Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study. Rheumatology (Oxford) 1999;38(7):608–611. doi: 10.1093/rheumatology/38.7.608. PubMed DOI

Escalante A, Miller L, Beardmore TD. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis. J Rheumatol. 1993;20(8):1340–1344. PubMed

Jorgensen AN, Aagaard P, Frandsen U, Boyle E, Diederichsen LP. Blood-flow restricted resistance training in patients with sporadic inclusion body myositis: a randomized controlled trial. Scand J Rheumatol. 2018;47(5):400–409. doi: 10.1080/03009742.2017.1423109. PubMed DOI

Wallace A, Pietrusz A, Dewar E, Dudziec M, Jones K, Hennis P, Sterr A, Baio G, Machado PM, Laurá M, Skorupinska I, Skorupinska M, Butcher K, Trenell M, Reilly MM, Hanna MG, Ramdharry GM. Community exercise is feasible for neuromuscular diseases and can improve aerobic capacity. Neurology. 2019;92(15):e1773–e1e85. doi: 10.1212/WNL.0000000000007265. PubMed DOI PMC

de Oliveira DS, Borges IBP, de Souza JM, Gualano B, Pereira RMR, Shinjo SK. Exercise training attenuates insulin resistance and improves beta-cell function in patients with systemic autoimmune myopathies: a pilot study. Clin Rheumatol. 2019;38(12):3435–3442. doi: 10.1007/s10067-019-04738-4. PubMed DOI

Chung YL, Alexanderson H, Pipitone N, Morrison C, Dastmalchi M, Stahl-Hallengren C, et al. Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: six-month, double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2007;57(4):694–702. doi: 10.1002/art.22687. PubMed DOI

Henry CJ. Basal metabolic rate studies in humans: measurement and development of new equations. Public Health Nutr. 2005;8(7A):1133–1152. doi: 10.1079/PHN2005801. PubMed DOI

Roche A, Heymsfield S, Lohman T. Human body composition. Champaign: Human Kinetics Publishers; 1996.

Talluri T, Lietdke RJ, Evangelisti A, Talluri J, Maggia G. Fat-free mass qualitative assessment with bioelectric impedance analysis (BIA) Ann N Y Acad Sci. 1999;873(1 ELECTRICAL BI):94–98. doi: 10.1111/j.1749-6632.1999.tb09454.x. PubMed DOI

Salsabili H, Bahrpeyma F, Forogh B, Rajabali S. Dynamic stability training improves standing balance control in neuropathic patients with type 2 diabetes. J Rehabil Res Dev. 2011;48(7):775–786. doi: 10.1682/JRRD.2010.08.0160. PubMed DOI

Chen IC, Cheng PT, Chen CL, Chen SC, Chung CY, Yeh TH. Effects of balance training on hemiplegic stroke patients. Chang Gung Med J. 2002;25(9):583–590. PubMed

Dolezal BA, Potteiger JA. Concurrent resistance and endurance training influence basal metabolic rate in nondieting individuals. J Appl Physiol (1985) 1998;85(2):695–700. doi: 10.1152/jappl.1998.85.2.695. PubMed DOI

Jungblut SA, Frickmann H, Zimmermann B, Muller U, Bargon J. The effects of physical training on the body composition of patients with COPD. Pneumologie. 2009;63(7):374–379. doi: 10.1055/s-0029-1214713. PubMed DOI

Nemec M, Vernerova L, Laiferova N, Balazova M, Vokurkova M, Kurdiova T, et al. Altered dynamics of lipid metabolism in muscle cells from patients with idiopathic inflammatory myopathy is ameliorated by 6 months of training. J Physiol. 2021;599(1):207-29. PubMed

Cardiovascular risk in myositis patients compared with the general population

Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study

Hsp90 as a Myokine: Its Association with Systemic Inflammation after Exercise Interventions in Patients with Myositis and Healthy Subjects

Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study

Hsp90 Levels in Idiopathic Inflammatory Myopathies and Their Association With Muscle Involvement and Disease Activity: A Cross-Sectional and Longitudinal Study